Sanj K Patel, Chairman and CEO of Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA), filed a Form 4 on September 3, 2026, disclosing multiple equity transactions dated September 1, 2026, including RSU vestings, a share disposition, and new equity grants.
Key Highlights
- RSU vestings: Patel reported four restricted share unit (RSU) vesting events on September 1, 2026, covering 9,991, 6,481, 6,237, and 8,609 Class A Ordinary Shares, all acquired indirectly through The Patel Family Irrevocable Trust of 2025.
- Shares disposed: 15,144 Class A Ordinary Shares were disposed of at $79.28 per share, also held indirectly by The Patel Family Irrevocable Trust of 2025, reducing that trust's holdings to 92,348 shares.
- New RSU grant: 30,050 RSUs were granted to Patel directly on September 1, 2026, vesting over four years at 25% per yearly anniversary of the grant date.
- New share option grant: A share option covering 120,150 Class A Ordinary Shares was granted at an exercise price of $79.28, with a vesting commencement date of September 1, 2026, and an expiration date of August 31, 2036.
- Additional indirect holdings: The filing reports 109,795 Class A Ordinary Shares held by The Marina 2016 Irrevocable Trust and 51,794 shares held by The Anglia 2013 Revocable Trust.
Details of Sanj K Patel's September 2026 Equity Transactions at Kiniksa Pharmaceuticals
According to the filing, all transactions were dated September 1, 2026. The four RSU vesting events (transaction code "M") converted contingent rights into Class A Ordinary Shares, with each RSU representing the right to receive one share. The vesting RSUs originated from grants dated September 1, 2022, September 1, 2023, September 1, 2024, and September 1, 2025, each structured to vest over four years at 25% per yearly anniversary. All vested shares were received indirectly through The Patel Family Irrevocable Trust of 2025.
Separately, 15,144 Class A Ordinary Shares were disposed of (transaction code "F") at $79.28 per share from the same trust, leaving that trust with 92,348 shares following the transaction. The filing does not specify the reason for this disposition beyond the transaction code.
On the same date, Patel received two new direct grants: 30,050 RSUs vesting over four years beginning September 1, 2026, and a share option for 120,150 Class A Ordinary Shares at an exercise price of $79.28 per share. The option vests as to 25% on the first anniversary of the vesting commencement date, with the remainder vesting in 36 equal monthly installments thereafter, expiring August 31, 2036. Both new grants carry a reported price of $0 for the derivative security itself. The filing was signed by Douglas Barry as Attorney-in-Fact on September 3, 2026.
What Was Disclosed
The filing disclosed RSU vestings, a share disposal at $79.28, and new grants of RSUs and a share option to Kiniksa's Chairman and CEO Sanj K Patel, with transactions occurring on September 1, 2026, and the form filed September 3, 2026.




Please wait processing your request...